Endocardium in Hypoplastic Left Heart Syndrome: Implications from In Vitro Study
Abstract
:1. Introduction
2. Pathology of Endocardium in HLHS
3. In Vitro Study of HLHS–iPSC Is an Emerging Technology in Disease Modeling
4. iPSC Modeling in Studying Endocardial Defects in HLHS
5. Current Challenges of iPSC-EEC Modeling for HLHS
6. Future Perspective
7. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Alphonso, N.; Angelini, A.; Barron, D.J.; Bellsham-Revell, H.; Blom, N.A.; Brown, K.; Davis, D.; Duncan, D.; Fedrigo, M.; Galletti, L.; et al. Guidelines for the management of neonates and infants with hypoplastic left heart syndrome: The European Association for Cardio-Thoracic Surgery (EACTS) and the Association for European Paediatric and Congenital Cardiology (AEPC) Hypoplastic Left Heart Syndrome Guidelines Task Force. Eur. J. Cardiothorac. Surg. 2020, 58, 416–499. [Google Scholar] [PubMed]
- Crucean, A.; Alqahtani, A.; Barron, D.J.; Brawn, W.J.; Richardson, R.V.; O’Sullivan, J.; Anderson, R.H.; Henderson, D.J.; Chaudhry, B. Re-evaluation of hypoplastic left heart syndrome from a developmental and morphological perspective. Orphanet. J. Rare Dis. 2017, 12, 138. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Harris, I.S.; Black, B.L. Development of the Endocardium. Pediatr. Cardiol. 2010, 31, 391–399. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Qu, X.; Harmelink, C.; Baldwin, H.S. Endocardial-Myocardial Interactions During Early Cardiac Differentiation and Trabeculation. Front. Cardiovasc. Med. 2022, 9, 857581. [Google Scholar] [CrossRef] [PubMed]
- Sharma, V.; Hecker, N.; Roscito, J.G.; Foerster, L.; Langer, B.E.; Hiller, M. A genomics approach reveals insights into the importance of gene losses for mammalian adaptations. Nat. Commun. 2018, 9, 1215. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wu, B.; Wang, Y.; Lui, W.; Langworthy, M.; Tompkins, K.L.; Hatzopoulos, A.K.; Baldwin, H.S.; Zhou, B. Nfatc1 Coordinates Valve Endocardial Cell Lineage Development Required for Heart Valve Formation. Circ. Res. 2011, 109, 183–192. [Google Scholar] [CrossRef] [Green Version]
- Zeisberg, E.M.; Tarnavski, O.; Zeisberg, M.; Dorfman, A.L.; McMullen, J.R.; Gustafsson, E.; Chandraker, A.; Yuan, X.; Pu, W.T.; Roberts, A.B.; et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 2007, 13, 952–961. [Google Scholar] [CrossRef]
- Xu, X.; Friehs, I.; Zhong Hu, T.; Melnychenko, I.; Tampe, B.; Alnour, F.; Iascone, M.; Kalluri, R.; Zeisberg, M.; Del Nido, P.J.; et al. Endocardial Fibroelastosis Is Caused by Aberrant Endothelial to Mesenchymal Transition. Circ. Res. 2015, 116, 857–866. [Google Scholar] [CrossRef] [Green Version]
- Weixler, V.H.M.; Zurakowski, D.; Kheir, J.; Guariento, A.; Kaza, A.K.; Baird, C.W.; Del Nido, P.J.; Emani, S.M. Fontan with lateral tunnel is associated with improved survival compared with extracardiac conduit. J. Thorac. Cardiovasc. Surg. 2020, 159, 1480–1491.e2. [Google Scholar] [CrossRef] [Green Version]
- Oh, N.A.; Hong, X.; Doulamis, I.P.; Meibalan, E.; Peiseler, T.; Melero-Martin, J.; García-Cardeña, G.; Del Nido, P.J.; Friehs, I. Abnormal Flow Conditions Promote Endocardial Fibroelastosis Via Endothelial-to-Mesenchymal Transition, Which Is Responsive to Losartan Treatment. JACC Basic Transl. Sci. 2021, 6, 984–999. [Google Scholar] [CrossRef]
- Rhee, S.; Paik, D.T.; Yang, J.Y.; Nagelberg, D.; Williams, I.; Tian, L.; Roth, R.; Chandy, M.; Ban, J.; Belbachir, N.; et al. Endocardial/endothelial angiocrines regulate cardiomyocyte development and maturation and induce features of ventricular non-compaction. Eur. Heart J. 2021, 42, 4264–4276. [Google Scholar] [CrossRef] [PubMed]
- Miao, Y.; Tian, L.; Martin, M.; Paige, S.L.; Galdos, F.X.; Li, J.; Klein, A.; Zhang, H.; Ma, N.; Wei, Y.; et al. Intrinsic Endocardial Defects Contribute to Hypoplastic Left Heart Syndrome. Cell Stem Cell. 2020, 27, 574–589.e8. [Google Scholar] [CrossRef] [PubMed]
- Jin, S.C.; Homsy, J.; Zaidi, S.; Lu, Q.; Morton, S.; Depalma, S.R.; Zeng, X.; Qi, H.; Chang, W.; Sierant, M.C.; et al. Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nat. Genet. 2017, 49, 1593–1601. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Theis, J.L.; Hu, J.J.; Sundsbak, R.S.; Evans, J.M.; Bamlet, W.R.; Qureshi, M.Y.; O’Leary, P.W.; Olson, T.M. Genetic Association Between Hypoplastic Left Heart Syndrome and Cardiomyopathies. Circ. Genom. Precis. Med. 2021, 14, e003126. [Google Scholar] [CrossRef] [PubMed]
- Belman, A.L.; Krupp, L.B.; Olsen, C.S.; Rose, J.W.; Aaen, G.; Benson, L.; Chitnis, T.; Gorman, M.; Graves, J.; Harris, Y.; et al. Characteristics of Children and Adolescents With Multiple Sclerosis. Pediatrics 2016, 138, e20160120. [Google Scholar] [CrossRef] [Green Version]
- Yagi, H.; Liu, X.; Gabriel, G.C.; Wu, Y.; Peterson, K.; Murray, S.A.; Aronow, B.J.; Martin, L.J.; Benson, D.W.; Lo, C.W. The Genetic Landscape of Hypoplastic Left Heart Syndrome. Pediatr. Cardiol. 2018, 39, 1069–1081. [Google Scholar] [CrossRef]
- Rahman, A.; Deyoung, T.; Cahill, L.S.; Yee, Y.; Debebe, S.K.; Botelho, O.; Seed, M.; Chaturvedi, R.R.; Sled, J.G. A mouse model of hypoplastic left heart syndrome demonstrating left heart hypoplasia and retrograde aortic arch flow. Dis. Model. Mech. 2021, 14, dmm049077. [Google Scholar] [CrossRef]
- Takahashi, K.; Yamanaka, S. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell 2006, 126, 663–676. [Google Scholar] [CrossRef] [Green Version]
- Gaber, N.; Gagliardi, M.; Patel, P.; Kinnear, C.; Zhang, C.; Chitayat, D.; Shannon, P.; Jaeggi, E.; Tabori, U.; Keller, G.; et al. Fetal Reprogramming and Senescence in Hypoplastic Left Heart Syndrome and in Human Pluripotent Stem Cells during Cardiac Differentiation. Am. J. Pathol. 2013, 183, 720–734. [Google Scholar] [CrossRef] [Green Version]
- Hrstka, S.C.L.; Li, X.; Nelson, T.J. NOTCH1-Dependent Nitric Oxide Signaling Deficiency in Hypoplastic Left Heart Syndrome Revealed Through Patient-Specific Phenotypes Detected in Bioengineered Cardiogenesis. Stem Cells 2017, 35, 1106–1119. [Google Scholar] [CrossRef]
- Jiang, Y.; Habibollah, S.; Tilgner, K.; Collin, J.; Barta, T.; Al-Aama, J.Y.; Tesarov, L.; Hussain, R.; Trafford, A.W.; Kirkwood, G.; et al. An Induced Pluripotent Stem Cell Model of Hypoplastic Left Heart Syndrome (HLHS) Reveals Multiple Expression and Functional Differences in HLHS-Derived Cardiac Myocytes. Stem Cells Transl. Med. 2014, 3, 416–423. [Google Scholar] [CrossRef] [PubMed]
- Paige, S.L.; Galdos, F.X.; Lee, S.; Chin, E.T.; Ranjbarvaziri, S.; Feyen, D.A.M.; Darsha, A.K.; Xu, S.; Ryan, J.A.; Beck, A.L.; et al. Patient-Specific Induced Pluripotent Stem Cells Implicate Intrinsic Impaired Contractility in Hypoplastic Left Heart Syndrome. Circulation 2020, 142, 1605–1608. [Google Scholar] [CrossRef] [PubMed]
- Yang, C.; Xu, Y.; Yu, M.; Lee, D.; Alharti, S.; Hellen, N.; Ahmad Shaik, N.; Banaganapalli, B.; Sheikh Ali Mohamoud, H.; Elango, R.; et al. Induced pluripotent stem cell modelling of HLHS underlines the contribution of dysfunctional NOTCH signalling to impaired cardiogenesis. Hum. Mol. Genet. 2017, 26, 3031–3045. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Silva, A.C.; Pereira, C.; Fonseca, A.; Pinto-do-Ó, P.; Nascimento, D.S. Bearing My Heart: The Role of Extracellular Matrix on Cardiac Development, Homeostasis, and Injury Response. Front. Cell Dev. Biol. 2020, 8, 621644. [Google Scholar] [CrossRef] [PubMed]
- Zhang, H.; Huang, X.; Liu, K.; Tang, J.; He, L.; Pu, W.; Liu, Q.; Li, Y.; Tian, X.; Wang, Y.; et al. Fibroblasts in an endocardial fibroelastosis disease model mainly originate from mesenchymal derivatives of epicardium. Cell Res. 2017, 27, 1157–1177. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chaudhry, B.; Alqahtani, A.; Eley, L.; Coats, L.; Moldovan, C.; Annavarapu, S.R.; Henderson, D.J. The Left Ventricular Myocardium in Hypoplastic Left Heart Syndrome. J. Cardiovasc. Dev. Dis. 2022, 9, 279. [Google Scholar] [CrossRef]
- Gillich, A.; Zhang, F.; Farmer, C.G.; Travaglini, K.J.; Tan, S.Y.; Gu, M.; Zhou, B.; Feinstein, J.A.; Krasnow, M.A.; Metzger, R.J. Capillary cell-type specialization in the alveolus. Nature 2020, 586, 785–789. [Google Scholar] [CrossRef]
- Hulin, A.; Hortells, L.; Gomez-Stallons, M.V.; O’Donnell, A.; Chetal, K.; Adam, M.; Lancellotti, P.; Oury, C.; Potter, S.S.; Salomonis, N.; et al. Maturation of heart valve cell populations during postnatal remodeling. Development 2019, 146, dev173047. [Google Scholar] [CrossRef] [Green Version]
- Su, T.; Stanley, G.; Sinha, R.; D’Amato, G.; Das, S.; Rhee, S.; Chang, A.H.; Poduri, A.; Raftrey, B.; Dinh, T.T.; et al. Single-cell analysis of early progenitor cells that build coronary arteries. Nature 2018, 559, 356–362. [Google Scholar] [CrossRef]
- Bittle, G.J.; Morales, D.; Deatrick, K.B.; Parchment, N.; Saha, P.; Mishra, R.; Sharma, S.; Pietris, N.; Vasilenko, A.; Bor, C.; et al. Stem Cell Therapy for Hypoplastic Left Heart Syndrome. Circ. Res. 2018, 123, 288–300. [Google Scholar] [CrossRef]
- Pierpont, M.E.; Brueckner, M.; Chung, W.K.; Garg, V.; Lacro, R.V.; McGuire, A.L.; Mital, S.; Priest, J.R.; Pu, W.T.; Roberts, A.; et al. Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association. Circulation 2018, 138, e653–e711. [Google Scholar] [CrossRef] [PubMed]
- Tinker, S.C.; Gilboa, S.M.; Moore, C.A.; Waller, D.K.; Simeone, R.M.; Kim, S.Y.; Jamieson, D.J.; Botto, L.D.; Fisher, S.C.; Reefhuis, J.; et al. Modification of the association between diabetes and birth defects by obesity, National Birth Defects Prevention Study, 1997–2011. Birth Defects Res. 2021, 113, 1084–1097. [Google Scholar] [CrossRef] [PubMed]
- Hoang, T.T.; Marengo, L.K.; Mitchell, L.E.; Canfield, M.A.; Agopian, A.J. Original Findings and Updated Meta-Analysis for the Association Between Maternal Diabetes and Risk for Congenital Heart Disease Phenotypes. Am. J. Epidemiol. 2017, 186, 118–128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Belmont, J.W. Considering the Genetic Architecture of Hypoplastic Left Heart Syndrome. J. Cardiovasc. Dev. Dis. 2022, 9, 315. [Google Scholar] [CrossRef] [PubMed]
- Mikryukov, A.A.; Mazine, A.; Wei, B.; Yang, D.; Miao, Y.; Gu, M.; Keller, G.M. BMP10 Signaling Promotes the Development of Endocardial Cells from Human Pluripotent Stem Cell-Derived Cardiovascular Progenitors. Cell Stem Cell 2021, 28, 96–111.e7. [Google Scholar] [CrossRef]
- Bao, X.; Bhute, V.J.; Han, T.; Qian, T.; Lian, X.; Palecek, S.P. Human pluripotent stem cell-derived epicardial progenitors can differentiate to endocardial-like endothelial cells. Bioeng. Transl. Med. 2017, 2, 191–201. [Google Scholar] [CrossRef] [Green Version]
- Cheng, L.; Xie, M.; Qiao, W.; Song, Y.; Zhang, Y.; Geng, Y.; Xu, W.; Wang, L.; Wang, Z.; Huang, K.; et al. Generation and characterization of cardiac valve endothelial-like cells from human pluripotent stem cells. Commun. Biol. 2021, 4, 1039. [Google Scholar] [CrossRef]
- Neri, T.; Hiriart, E.; Van Vliet, P.P.; Faure, E.; Norris, R.A.; Farhat, B.; Jagla, B.; Lefrancois, J.; Sugi, Y.; Moore-Morris, T.; et al. Human pre-valvular endocardial cells derived from pluripotent stem cells recapitulate cardiac pathophysiological valvulogenesis. Nat. Commun. 2019, 10, 1929. [Google Scholar] [CrossRef] [Green Version]
- Zhu, L.; Liu, K.; Feng, Q.; Liao, Y. Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease. Stem Cell Rev. Rep. 2022, 18, 2593–2605. [Google Scholar] [CrossRef]
- Lewis-Israeli, Y.R.; Wasserman, A.H.; Gabalski, M.A.; Volmert, B.D.; Ming, Y.; Ball, K.A.; Yang, W.; Zou, J.; Ni, G.; Pajares, N.; et al. Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease. Nat. Commun. 2021, 12, 5142. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yu, Z.; Liu, Z.; Ravichandran, V.; Lami, B.; Gu, M. Endocardium in Hypoplastic Left Heart Syndrome: Implications from In Vitro Study. J. Cardiovasc. Dev. Dis. 2022, 9, 442. https://doi.org/10.3390/jcdd9120442
Yu Z, Liu Z, Ravichandran V, Lami B, Gu M. Endocardium in Hypoplastic Left Heart Syndrome: Implications from In Vitro Study. Journal of Cardiovascular Development and Disease. 2022; 9(12):442. https://doi.org/10.3390/jcdd9120442
Chicago/Turabian StyleYu, Zhiyun, Ziyi Liu, Vidhya Ravichandran, Bonny Lami, and Mingxia Gu. 2022. "Endocardium in Hypoplastic Left Heart Syndrome: Implications from In Vitro Study" Journal of Cardiovascular Development and Disease 9, no. 12: 442. https://doi.org/10.3390/jcdd9120442